NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Amarin Corporation plc (NASDAQ: AMRN)
AMRN Technical Analysis
5
As on 29th Nov 2024 AMRN STOCK Price closed @ 0.51 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.98 & Strong Sell for SHORT-TERM with Stoploss of 1.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AMRNSTOCK Price
Open | 0.50 | Change | Price | % |
High | 0.51 | 1 Day | 0.02 | 4.08 |
Low | 0.48 | 1 Week | 0.02 | 4.08 |
Close | 0.51 | 1 Month | -0.07 | -12.07 |
Volume | 670355 | 1 Year | -0.68 | -57.14 |
52 Week High 1.43 | 52 Week Low 0.48 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
NVDA | 138.25 | 2.15% |
LMDX | 0.02 | 0.00% |
MARA | 27.42 | 1.86% |
OPTT | 0.50 | 35.14% |
PONO | 1.72 | 2.38% |
TELL | 1.00 | 0.00% |
SMCI | 32.64 | -6.93% |
BTB | 0.03 | 0.00% |
TWKS | 4.47 | -0.45% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
AMRN Daily Charts |
AMRN Intraday Charts |
Whats New @ Bazaartrend |
AMRN Free Analysis |
|
AMRN Important Levels Intraday
RESISTANCE | 0.57 |
RESISTANCE | 0.55 |
RESISTANCE | 0.54 |
RESISTANCE | 0.53 |
SUPPORT | 0.49 |
SUPPORT | 0.48 |
SUPPORT | 0.47 |
SUPPORT | 0.45 |
AMRN Forecast December 2024
4th UP Forecast | 1.3 |
3rd UP Forecast | 1.05 |
2nd UP Forecast | 0.89 |
1st UP Forecast | 0.73 |
1st DOWN Forecast | 0.29 |
2nd DOWN Forecast | 0.13 |
3rd DOWN Forecast | -0.03 |
4th DOWN Forecast | -0.28 |
AMRN Weekly Forecast
4th UP Forecast | 0.78 |
3rd UP Forecast | 0.69 |
2nd UP Forecast | 0.64 |
1st UP Forecast | 0.59 |
1st DOWN Forecast | 0.43 |
2nd DOWN Forecast | 0.38 |
3rd DOWN Forecast | 0.33 |
4th DOWN Forecast | 0.24 |
AMRN Forecast2024
4th UP Forecast | 2.49 |
3rd UP Forecast | 1.86 |
2nd UP Forecast | 1.46 |
1st UP Forecast | 1.07 |
1st DOWN Forecast | -0.05 |
2nd DOWN Forecast | -0.44 |
3rd DOWN Forecast | -0.84 |
4th DOWN Forecast | -1.47 |
Amarin Corporation plc ( NASDAQ USA Symbol : AMRN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AMRN Other Details
Segment | EQ | |
Market Capital | 1846060416.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
AMRN Address
AMRN Latest News
AMRN Business Profile
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Address: Grand Canal Docklands, Dublin, Ireland, 2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service